Press Releases Spineway

Equities

Market Closed - Euronext Paris Other stock markets 11:17:38 2024-05-28 am EDT			5-day change	1st Jan Change
0.6462 ^EUR	+5.93%		+20.79%	-90.50%

Apr. 17	Spineway: punished despite a solid first quarter	CF
Apr. 16	Spineway SA Announces Revenue Results for the First Quarter of 2024	CI

Growth of 28% of 2024 first quarter revenue	Apr. 16	AQ
2023 Shareholders General Meeting	Mar. 26	AQ
Reverse stock split	Feb. 29	AQ
Preparatory documents for the General Meeting as of of March 25, 2024	Feb. 19	AQ
SPINEWAY : 2023 annual results	Feb. 07	AQ
Increase of 2023 revenue at €10.5 million	Jan. 25	AQ
Shares reverse split	Jan. 05	AQ
SPINEWAY : International rollout of the VEOS implant range - First implants in Spain - New approvals in Colombia and Indonesia	Nov. 24	AQ
Extraordinary General Meeting's minute	Nov. 13	AQ
Deputy Chief Executive Officer's appointment	Nov. 07	AQ
US 2023 NASS conference : VEOS System	Nov. 02	AQ
Spineway : Document AMF CP. 2023E935253	23-10-27	PU
Spineway : Document AMF CP. 2023E934680	23-10-25	PU
Spineway : Document AMF CP. 2023E934420	23-10-24	PU
VEOS FDA 510(k) clearance	23-10-19	AQ
Spineway : Document AMF CP. 2023E933058	23-10-16	PU
Revenue growth as of September 2023 by 40%	23-10-13	AQ
INTERNATIONAL MASTERCLASS	23-09-14	AQ
First-half 2023 revenue of € 5.4 million (+75%)	23-07-11	AQ
Strengthening of the cash position thanks to new financing	23-05-25	AQ

No results for this search